Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

278 requests
Make a request to this authority
GcMAF Effects on Cancer and Prosecution of David Noakes
Response by Medicines and Healthcare products Regulatory Agency to George Robinson on .

Awaiting classification.

Our Ref: FOI 19/090 Dear George Robinson, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on...
Fluoridated drinking water is used to prevent disease - why does it evade your regulation?
Request to Medicines and Healthcare products Regulatory Agency by Zac Cox. Annotated by George Robinson on .

Awaiting classification.

So this type of fluoride which harms people does not need regulating, yet GcMAF which would financially cripple big pharma does need regulating?
MHRA Yellow Card complaints regarding Ephdrine
Response by Medicines and Healthcare products Regulatory Agency to Lee Johnson on .

Successful.

FOI 19/013   Dear Mr Johnson,   Thank you for your email.   Please find attached the response to your FOI request.   Kind Regards  ...
Importation of Unlicensed Medicines
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Awaiting classification.

Dear Mr Kelly,   Thank you for your email.   Please find attached response.   Kind Regards   Customer Services Communications division...
Haemotherapy
Response by Medicines and Healthcare products Regulatory Agency to Phil Collyer on .

Awaiting classification.

Dear Mr Collyer,   Many thanks for your information request 19th January 2019 dated where you asked what forms of haemotherapy are legally allowed...
Liothyronine v Levothyroxine
Response by Medicines and Healthcare products Regulatory Agency to Allyson Bissett on .

Successful.

Dear Mrs Bissett, Please find attached, the final response to the above-referenced FOI request. Kind regards, FOI Licensing Team MHRA MHRA 10 South...
Parallel import licences for liothyronine.
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Awaiting response.

Our Ref: FOI 19/071 Dear Enquirer, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 7 Febr...
Request for a structured dataset on granted medicine licenses
Response by Medicines and Healthcare products Regulatory Agency to Brian Mac Kenna on .

Delayed.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Break-marks on UK liothyronine tablets do not comply with PH.Eur. monograph.
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Awaiting response.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Dates of the next 2 Public MHRA Board Meetings?
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Awaiting response.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Under FOI Please supply information on Thybon Henning 20mcg liothyronine, under Sanofi-Aventis
Response by Medicines and Healthcare products Regulatory Agency to U Power on .

Partially successful.

Dear Mrs U J Power,   Thank you for your email.   This is an unlicensed medicine, commonly imported to meet the special needs of individual pa...
Yellow Card Scheme/Liothyronine
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Partially successful.

Dear Ms Sanday,   Thank you for your email dated 04 January 2019, where you requested information regarding liothyronine. Please find our response...
MHRA updates of clinical trial statuses on EudraCT
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Successful.

Dear Dr Bruckner   Thank you for your email of 8 January 2019 requesting information on MHRA updates of clinical trial statuses on EudraCT.  ...
SPCs and PILs for discontinued products in the last eight years
Response by Medicines and Healthcare products Regulatory Agency to Vijay Singh on .

Awaiting classification.

FOI 19/107 Dear Vijay, Thank you for your email of 12 December where you have asked "I would be grateful if you could provide an excel sheet of medi...
MHRA regulation of medical products containing Ephedrine
Response by Medicines and Healthcare products Regulatory Agency to Lee Johnson on .

Successful.

FOI 18/648 Dear Lee Johnson, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Comm...
Numbers of Agency Lawyers 3 Sep 2018 and Cost of agency legal workers 2016/2017
Response by Medicines and Healthcare products Regulatory Agency to Ted Jones on .

Partially successful.

FOI 18/600 Dear Ted Jones, Thank you for your email of 7 November where you have asked 1 - How many lawyers were working on a temporary (agency) ba...
Companies who won tenders for fridges in the event of a no deal Brexit
Response by Medicines and Healthcare products Regulatory Agency to Lee Davies on .

Information not held.

Dear Lee Davies, Thank you for your email of 18 December where you have asked “Under the Freedom of Information Act I would like to know which compan...
Adverse vaccine reactions data from MMR vaccine
Response by Medicines and Healthcare products Regulatory Agency to Paul Russell on .

Successful.

FOI 17/121 Dear Mr Russell, Thank you for your email. Please find attached the response to your FOI request. Kind Regards, Customer Services...
Employee contracts
Response by Medicines and Healthcare products Regulatory Agency to Mike on .

Awaiting classification.

FOI 18/616   Dear Enquirer,   Thank you for your email of 19 November where you have asked “Please could I request a break down of MHRA staff...
Levothyroxine - is it orthomolecular
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Awaiting classification.

Dear Ms Sanday,   Thank you for your email.   The term “orthomolecular” means a “natural” medicine. Levothyroxine in the strict sense is not ortho...
Statistics of people suffering adverse from Rigevidon
Response by Medicines and Healthcare products Regulatory Agency to Sophie Long on .

Awaiting classification.

FOI 18/582   Dear Ms Long,   Thank you for your email.   Please find attached the response to your FOI request.   Kind Regards    ...
Infected Blood Inquiry Notice
Response by Medicines and Healthcare products Regulatory Agency to JJ Evans on .

Successful.

Dear Mr Evans, Thank you for your email. A response was sent to you yesterday and we have attached for your information. Kind Regards Customer Serv...
Mecial Control Agency Records Pre 1997
Response by Medicines and Healthcare products Regulatory Agency to Tania: of the Cocking Family on .

Information not held.

  Ms Cocking Please see attached correspondence regarding your recent FOI request.   Regards Chris Jones   Dr Chris Jones Manager – Med...
Funding and Fees from Pfizer
Response by Medicines and Healthcare products Regulatory Agency to Georgina Goulding on .

Partially successful.

FOI 18/590   Dear Georgina Goulding,   Thank you for your email.   Regarding your question ‘Please confirm what years can be covered if onl...
Reclassification of Cannabidiol as a medicine
Response by Medicines and Healthcare products Regulatory Agency to Sanders A on .

Partially successful.

3^rd November 2016 Allan Sanders Email: [1][FOI #363677 email]     Dear Mr Sanders   REF:  FOI 16/518   Thank you for your communicat...

Only requests made using WhatDoTheyKnow are shown. ?